C2 and myasthenia gravis: Plasma levels of the altered complement proteins (C2, C3, C3b, C5, and C5a) in the AChR-MG group did not linearly correlate with disease severity evaluated by MGC and MG-ADL scores, nor with anti-AChR Ab titers.